-
1
-
-
33845502898
-
Impact of Heparin Induced Thrombocytopenia on outcome in patients with ventricular assist device support: Single-institution experience in 358 consecutive atients
-
Koster A., Huebler S., Potapov E. et al. Impact of Heparin Induced Thrombocytopenia on outcome in patients with ventricular assist device support: Single-institution experience in 358 consecutive atients. Ann Thorac Surg 2007; 3: 72-76.
-
(2007)
Ann Thorac Surg
, vol.3
, pp. 72-76
-
-
Koster, A.1
Huebler, S.2
Potapov, E.3
-
2
-
-
33646848620
-
Heparin-induced-thrombocytopenia in patients receiving mechanical circulatory support
-
Schenk S., El-Banayosy A. et al. Heparin-induced-thrombocytopenia in patients receiving mechanical circulatory support. The Journal of Thoracic and Cardiovascular Surgery 2006; 131:137-1381.
-
(2006)
The Journal of Thoracic and Cardiovascular Surgery
, vol.131
, pp. 137-1381
-
-
Schenk, S.1
El-Banayosy, A.2
-
3
-
-
64649095956
-
Heparin-induced thrombocytopenia in patients with ventricular assist devices: Are new prevention strategies required?
-
Warkentin TE., Greinacher A., Koster A. Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required? Annals of thoracic surgery 2009; 87: 1633-1640.
-
(2009)
Annals of Thoracic Surgery
, vol.87
, pp. 1633-1640
-
-
Warkentin, T.E.1
Greinacher, A.2
Koster, A.3
-
4
-
-
42949123334
-
Argatroban as primary or secondary postoperative anticoagulant in patients implanted with ventricular assist devices
-
Samuels L., Kohout J., Casanova-Ghosh E. et al. Argatroban as primary or secondary postoperative anticoagulant in patients implanted with ventricular assist devices. Ann Thorac Surg 2008; 85: 1651-1655.
-
(2008)
Ann Thorac Surg
, vol.85
, pp. 1651-1655
-
-
Samuels, L.1
Kohout, J.2
Casanova-Ghosh, E.3
-
5
-
-
33745173460
-
Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia
-
Lewis B., Wallis D., Hursting, et al. Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia. Chest 2006;129:1407-1416.
-
(2006)
Chest
, vol.129
, pp. 1407-1416
-
-
Lewis, B.1
Wallis, D.2
Hursting3
-
6
-
-
0035836541
-
Argatroban Anticoagulant therapy in patients with Heparin-Induced Thrombocytopenia
-
Lewis B.E., Wallis D.E., et al. Argatroban Anticoagulant therapy in patients with Heparin-Induced Thrombocytopenia. Circulation 2001; 103: 1838-1843.
-
(2001)
Circulation
, vol.103
, pp. 1838-1843
-
-
Lewis, B.E.1
Wallis, D.E.2
-
7
-
-
33646492822
-
Argatroban Therapyin heparin-induced thrombocytopenia with hepatic dysfunction
-
Lewis B., Hursting M., McCollum D. Argatroban Therapyin heparin-induced thrombocytopenia with hepatic dysfunction. Chest 2006; 29: 1167-1175.
-
(2006)
Chest
, vol.29
, pp. 1167-1175
-
-
Lewis, B.1
Hursting, M.2
McCollum, D.3
-
8
-
-
45949103154
-
Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence- Based clinical practice Guidelines (8th edition)
-
Warkentin TE., Greinacher A., Koster A. et al. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence- Based clinical practice Guidelines (8th edition). Chest 2008; 133:340S-380S.
-
(2008)
Chest
, vol.133
-
-
Warkentin, T.E.1
Greinacher, A.2
Koster, A.3
-
9
-
-
33747776199
-
Anticoagulation with argatroban in patients with heparin-induced thrombocytopenia antibodies after cardiovascular surgery with cardiopulmonary bypass: First result from the ARGE03 trial
-
Koster A., Buz S., Hetzer R. et al. Anticoagulation with argatroban in patients with heparin-induced thrombocytopenia antibodies after cardiovascular surgery with cardiopulmonary bypass: First result from the ARGE03 trial. The Journal of Thoracic and Cardiovascular Surgery 2006; 132: 699-700.
-
(2006)
The Journal of Thoracic and Cardiovascular Surgery
, vol.132
, pp. 699-700
-
-
Koster, A.1
Buz, S.2
Hetzer, R.3
-
10
-
-
34548041395
-
Heparin- Induced Thrombocytopenia in left ventricular assist device bridge to transplant patients
-
Schroder J., Daneshmand M., Villamizar N. et al. Heparin- Induced Thrombocytopenia in left ventricular assist device bridge to transplant patients. Ann Thorac Surg 2007; 84: 841-846.
-
(2007)
Ann Thorac Surg
, vol.84
, pp. 841-846
-
-
Schroder, J.1
Daneshmand, M.2
Villamizar, N.3
-
11
-
-
59649086734
-
Argatroban therapyin continous renal replacement therapy
-
Link A., Girndt M., Selejan S. et al. Argatroban therapyin continous renal replacement therapy. Crit Care Med 2009; 37(1): 105-110.
-
(2009)
Crit Care Med
, vol.37
, Issue.1
, pp. 105-110
-
-
Link, A.1
Girndt, M.2
Selejan, S.3
-
12
-
-
34247467080
-
Argatroban anticoagulation for renal replacement therapy in patients with heparin-induced thrombocytopenia after cardiovascular surgery
-
Koster A., Hentschel T., Groman T. et al. Argatroban anticoagulation for renal replacement therapy in patients with heparin-induced thrombocytopenia after cardiovascular surgery. J Thorac Cardiovasc Surg 2007; 133: 1376-1377.
-
(2007)
J Thorac Cardiovasc Surg
, vol.133
, pp. 1376-1377
-
-
Koster, A.1
Hentschel, T.2
Groman, T.3
-
13
-
-
34548079462
-
Influence of argatroban on coagulation parameters in heparin-induced thrombocytopenia patients after cardiac surgery
-
Harder S., Merz M., Klinkhardt U. et al. Influence of argatroban on coagulation parameters in heparin-induced thrombocytopenia patients after cardiac surgery. J Thromb Haemost 2007; 5:1982-1984.
-
(2007)
J Thromb Haemost
, vol.5
, pp. 1982-1984
-
-
Harder, S.1
Merz, M.2
Klinkhardt, U.3
|